Dyslipidaemia and cardiovascular risk in diabetes (Q34168379)

31 July 2017

1 reference

title

Dyslipidaemia and cardiovascular risk in diabetes (English)

1 reference

31 July 2017

1 reference

1 reference

Cullen P

1

1 reference

31 July 2017

von Eckardstein A

2

1 reference

31 July 2017

Souris S

3

1 reference

31 July 2017

Schulte H

4

1 reference

31 July 2017

Assmann G

5

1 reference

31 July 2017

1 July 1999

1 reference

Diabetes, Obesity and Metabolism

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

189-198

1 reference

31 July 2017

4

1 reference

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Mortality, place and mode of death and reinfarction during a period of 5 years after acute myocardial infarction in diabetic and non-diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Early mortality after acute myocardial infarction: observational study in Yamagata, 1993-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Plasma lipoprotein abnormalities in type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Plasma lipid levels in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Genetic influences on lipoprotein(a) concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

The mysteries of lipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Familial dyslipidaemic hypertension and other multiple metabolic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Mechanisms of fatty acid-induced inhibition of glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Comparison of statins in hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00030.X

10.1046/J.1463-1326.1999.00030.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference